Applied DNA Sciences, Inc. (APDN)

USD 0.89

(-2.09%)

Long Term Debt Summary of Applied DNA Sciences, Inc.

  • Applied DNA Sciences, Inc.'s latest annual long term debt in 2023 was 739.16 Thousand USD , down 0.0% from previous year.
  • Applied DNA Sciences, Inc.'s latest quarterly long term debt in 2024 Q2 was 472.39 Thousand USD , down -100.0% from previous quarter.
  • Applied DNA Sciences, Inc. reported annual long term debt of - USD in 2022, down 0.0% from previous year.
  • Applied DNA Sciences, Inc. reported annual long term debt of - USD in 2021, down -100.0% from previous year.
  • Applied DNA Sciences, Inc. reported quarterly long term debt of 607.28 Thousand USD for 2024 Q1, down -17.84% from previous quarter.
  • Applied DNA Sciences, Inc. reported quarterly long term debt of 334.4 Thousand USD for 2024 Q3, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Applied DNA Sciences, Inc. (2023 - 1998)

Created with Highcharts 11.1.0YearsLong Term Debt19982000200220042006200820102012201420162018202020220 USD1000000 USD2000000 USD3000000 USD4000000 USD5000000 USD6000000 USD

Historical Annual Long Term Debt of Applied DNA Sciences, Inc. (2023 - 1998)

Year Long Term Debt Long Term Debt Growth
2023 739.16 Thousand USD 0.0%
2022 - USD 0.0%
2021 - USD -100.0%
2020 517.48 Thousand USD -66.51%
2019 1.54 Million USD -2.61%
2018 1.58 Million USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD -100.0%
2010 219.71 Thousand USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD -100.0%
2006 4.53 Million USD 0.0%
2005 - USD 0.0%
2004 - USD -100.0%
2003 88.5 Thousand USD 0.0%
2002 - USD 0.0%
2001 - USD 0.0%
2000 - USD 0.0%
1999 - USD 0.0%
1998 - USD 0.0%

Peer Long Term Debt Comparison of Applied DNA Sciences, Inc.

Name Long Term Debt Long Term Debt Difference
Aclaris Therapeutics, Inc. 3.07 Million USD 75.954%
Biodesix, Inc. 35.22 Million USD 97.902%
bioAffinity Technologies, Inc. 1.11 Million USD 33.913%
Castle Biosciences, Inc. 14.19 Million USD 94.794%
DarioHealth Corp. 24.59 Million USD 96.994%
Exact Sciences Corporation 2.47 Billion USD 99.97%
IDEXX Laboratories, Inc. 622.88 Million USD 99.881%
Illumina, Inc. 1.48 Billion USD 99.95%
Intelligent Bio Solutions Inc. 81.32 Thousand USD -808.91%
iSpecimen Inc. 29.13 Thousand USD -2437.46%
Standard BioTools Inc. 3.98 Million USD 81.442%
23andMe Holding Co. 67.84 Million USD 98.911%
Medpace Holdings, Inc. 142.12 Million USD 99.48%
NeoGenomics, Inc. 606.06 Million USD 99.878%
Inotiv, Inc. 399.4 Million USD 99.815%
Psychemedics Corporation 945 Thousand USD 21.782%
Prenetics Global Limited 867.21 Thousand USD 14.766%
Precipio, Inc. 106 Thousand USD -597.323%
RadNet, Inc. 812.06 Million USD 99.909%
Sotera Health Company 2.22 Billion USD 99.967%
Star Equity Holdings, Inc. 1.14 Million USD 35.444%
Exagen Inc. 19.23 Million USD 96.156%
Natera, Inc. 282.94 Million USD 99.739%
Aspira Women's Health Inc. 1.43 Million USD 48.31%
Neogen Corporation 888.39 Million USD 99.917%
Myriad Genetics, Inc. 130.9 Million USD 99.435%
ICON Public Limited Company 3.66 Billion USD 99.98%
Bionano Genomics, Inc. 7.17 Million USD 89.698%
CareDx, Inc 28.27 Million USD 97.386%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 79.17 Million USD 99.066%
Guardant Health, Inc. 1.13 Billion USD 99.935%
BioNexus Gene Lab Corp. 98.76 Thousand USD -648.42%
Fulgent Genetics, Inc. 10.11 Million USD 92.69%
Sera Prognostics, Inc. 840 Thousand USD 12.005%
OPKO Health, Inc. 222.03 Million USD 99.667%
Personalis, Inc. 1.23 Million USD 40.1%
Star Equity Holdings, Inc. 1.14 Million USD 35.444%
MDxHealth SA 35.56 Million USD 97.922%
Prenetics Global Limited 867.21 Thousand USD 14.766%
ENDRA Life Sciences Inc. 192.06 Thousand USD -284.856%
Mainz Biomed B.V. 2.19 Million USD 66.339%
Trinity Biotech plc 54.65 Million USD 98.647%
Neuronetics, Inc. 59.28 Million USD 98.753%
bioAffinity Technologies, Inc. 1.11 Million USD 33.913%